Literature DB >> 23486795

Antidepressants for functional gastrointestinal disorders in children.

Edmund Tan1, Christine H Smith, Ran D Goldman.   

Abstract

QUESTION: Functional gastrointestinal disorders (FGIDs) are complex conditions I see in some of my pediatric patients. The indications for antidepressants such as selective serotonin reuptake inhibitors (SSRIs) do not include treatment of FGIDs; however, some children are prescribed SSRIs for this condition. Are antidepressants effective and safe to use for treating FGIDs in children and adolescents? ANSWER: The pathogenesis of FGIDs is largely idiopathic, and although theories exist to explain why SSRIs might be used to treat FGIDs, there is no conclusive evidence of their effectiveness. No large, well controlled studies have investigated the use of SSRIs to treat FGIDs in the pediatric population. There is also evidence that suggests an increased risk of suicidal thoughts when adolescents use SSRIs. Currently, there is no recommendation to use SSRIs to treat FGIDs in children.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23486795      PMCID: PMC3596202     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  11 in total

1.  Citalopram provides little or no benefit in nondepressed patients with irritable bowel syndrome.

Authors:  Uri Ladabaum; Annie Sharabidze; Theodore R Levin; Wei K Zhao; Elaine Chung; Peter Bacchetti; Chengshi Jin; Barbara Grimes; Craig J Pepin
Journal:  Clin Gastroenterol Hepatol       Date:  2009-09-16       Impact factor: 11.382

2.  Abdominal pain and irritable bowel syndrome in adolescents: a community-based study.

Authors:  J S Hyams; G Burke; P M Davis; B Rzepski; P A Andrulonis
Journal:  J Pediatr       Date:  1996-08       Impact factor: 4.406

Review 3.  Management of functional abdominal pain and irritable bowel syndrome in children and adolescents.

Authors:  Eric Chiou; Samuel Nurko
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2010-06       Impact factor: 3.869

4.  Childhood functional gastrointestinal disorders: child/adolescent.

Authors:  Andrée Rasquin; Carlo Di Lorenzo; David Forbes; Ernesto Guiraldes; Jeffrey S Hyams; Annamaria Staiano; Lynn S Walker
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

5.  Multicenter, randomized, placebo-controlled trial of amitriptyline in children with functional gastrointestinal disorders.

Authors:  Miguel Saps; Nader Youssef; Adrian Miranda; Samuel Nurko; Paul Hyman; Jose Cocjin; Carlo Di Lorenzo
Journal:  Gastroenterology       Date:  2009-07-31       Impact factor: 22.682

6.  Citalopram treatment of pediatric recurrent abdominal pain and comorbid internalizing disorders: an exploratory study.

Authors:  John V Campo; James Perel; Amanda Lucas; Jeff Bridge; Mary Ehmann; Catherine Kalas; Kelly Monk; David Axelson; Boris Birmaher; Neal Ryan; Carlo Di Lorenzo; David A Brent
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2004-10       Impact factor: 8.829

7.  A prospective school-based study of abdominal pain and other common somatic complaints in children.

Authors:  Miguel Saps; Roopa Seshadri; Marcelo Sztainberg; Gilda Schaffer; Beth M Marshall; Carlo Di Lorenzo
Journal:  J Pediatr       Date:  2008-11-28       Impact factor: 4.406

8.  Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.

Authors:  Jeffrey A Bridge; Satish Iyengar; Cheryl B Salary; Rémy P Barbe; Boris Birmaher; Harold Alan Pincus; Lulu Ren; David A Brent
Journal:  JAMA       Date:  2007-04-18       Impact factor: 56.272

Review 9.  Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.

Authors:  S Hetrick; S Merry; J McKenzie; P Sindahl; M Proctor
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18

Review 10.  Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis.

Authors:  A C Ford; N J Talley; P S Schoenfeld; E M M Quigley; P Moayyedi
Journal:  Gut       Date:  2008-11-10       Impact factor: 23.059

View more
  1 in total

1.  Searching the cytochrome p450 enzymes for the metabolism of meranzin hydrate: a prospective antidepressant originating from Chaihu-Shugan-San.

Authors:  Xi Huang; Ying Guo; Wei-Hua Huang; Wei Zhang; Zhi-Rong Tan; Jing-Bo Peng; Yi-Cheng Wang; Dong-Li Hu; Dong-Sheng Ouyang; Jian Xiao; Yang Wang; Min Luo; Yao Chen
Journal:  PLoS One       Date:  2014-11-26       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.